Trinidad and Tobago vs United States: Immunization, Hib3
Trinidad and Tobago
92.0%
in 2024
United States
92.0%
in 2024
Trinidad and Tobago rank
84th
United States rank
84th
Immunization, Hib3 over time
- Trinidad and Tobago
- United States
How they compare
Trinidad and Tobago currently reports 92.0% against 92.0% in United States, a difference of 0.0%.
The two have swapped places 8 times across 27 shared years of data; in 1998 it was United States ahead.
Trinidad and Tobago ranks 84th and United States ranks 84th of 191 countries.
Across the 4 decades both report, Trinidad and Tobago averaged higher in 1 and United States in 2.
Head to head by decade
| Decade | Trinidad and Tobago | United States | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 28.5% | 93.5% | 65.0% | United States |
| 2000s | 85.6% | 92.2% | 6.6% | United States |
| 2010s | 92.4% | 92.4% | 0.0% | — |
| 2020s | 94.2% | 91.6% | 2.6% | Trinidad and Tobago |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Trinidad and Tobago or United States?
- Trinidad and Tobago, at 92.0% against 92.0% in United States as of 2024.
- What is the difference in immunization, hib3 between Trinidad and Tobago and United States?
- 0.0%, with Trinidad and Tobago ahead.
- How many years of comparable data are there for Trinidad and Tobago and United States?
- 27 years are reported by both, from 1998 to 2024.
- How do Trinidad and Tobago and United States rank globally for immunization, hib3?
- Trinidad and Tobago ranks 84th and United States ranks 84th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.